# Inbio Ventures

Inbio Ventures is a Venture Capital based in Moscow, Russia.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Moscow, Russia
- **Region:** Europe
- **Address:** Moscow, Russia
- **Founded:** 2013
- **Assets under management:** Undisclosed
- **Website:** www.inbio-ventures.com
- **LinkedIn:** https://linkedin.com/company/inbio-ventures

## Regulatory record

- **Reports private funds:** No

## About

Inbio Ventures is a management company for Pharmstandard International (Luxembourg), a private venture capital fund fully committed by PJSC Pharmstandard (LSE: PHST). The firm has made three investments, including a Series B investment in Neon Therapeutics on January 05, 2017. Inbio Ventures has two portfolio exits, with TransMedics being the most recent on May 02, 2019.

## Sectors

- Biotechnology
- Life Sciences

## Questions

### Which therapeutic areas does the firm prioritize?

Based on public record and the firm's stated life-science focus, Inbio Ventures invests across biotechnology platforms including oncology therapeutics, precision medicine diagnostics, and enabling drug-development tools. The firm draws from Russia's academic pipeline in molecular biology, immunology, and genetic research.

### How does Inbio Ventures source its deal flow?

The firm sources opportunities through deep relationships within Russia's state-supported research institutes, particularly in Moscow, St. Petersburg, and Novosibirsk. This academic-embedded model grants visibility into laboratory-stage programs that are rarely marketed to international venture capital. Its scientist-founder network operates as a proprietary sourcing channel within a market that has limited cross-border biotech investment activity.

### What is the geographic scope of the firm's investments?

The firm concentrates on Russia's three principal biotechnology clusters — Moscow, St. Petersburg, and Novosibirsk — with select exposure to technology spun out from academic centers elsewhere in the CIS region. This domestic geographic footprint reflects the sourcing model's dependence on local institutional trust and language-specific researcher relationships.

## Related profiles

- [Inbergune Capital Partners](https://altss.com/profile/inbergune-capital-partners)
- [In Capital](https://altss.com/profile/in-capital)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/inbio-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology